# Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)

> **NCT00630890** · PHASE1 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 11 (actual)

## Conditions studied

- Cholangiocarcinoma
- Klatskin Tumor
- Biliary Tract Cancer

## Interventions

- **RADIATION:** External beam radiation and Cyberknife radiosurgery boost and capecitabine

## Key facts

- **NCT ID:** NCT00630890
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** investigator left UCSF and study was closed prematurely in 2008. No results to report.
- **Last updated:** 2015-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630890, "Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00630890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*